Table of Content

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Neurostimulation Devices Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Prevalence of Neurological Disorders
3.2.1.2 Growing Investments by Companies and Organizations Across the Globe
3.2.1.3 Technological Advancements in Neurostimulation Devices
3.2.2 Market Restraining Factors
3.2.2.1 Complications Associated with Usage of Neurostimulation Devices
3.2.2.2 Lack of Skilled Healthcare Practitioners
3.2.3 Market Opportunities
3.2.3.1 Rising Demand for Minimally Invasive Surgeries in Developed Countries
3.2.3.2 Increasing Number of Elderly Patients with Neurological Disorders
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Neurostimulation Devices Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Neurostimulation Devices Market Size Estimation and Forecast by Product
4.4 Deep Brain Stimulator(DBS)
4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Gastric Electric Stimulator(GES)
4.5.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Spinal Cord Stimulator(SCS)
4.6.1 Market Size by Region, 2023-2033 (US$ Mn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Sacral Nerve Stimulator
4.7.1 Market Size by Region, 2023-2033 (US$ Mn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Vagus Nerve Stimulator
4.8.1 Market Size by Region, 2023-2033 (US$ Mn)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Transcutaneous Electrical Nerve Stimulation (TENS)
4.9.1 Market Size by Region, 2023-2033 (US$ Mn)
4.9.2 Market Share by Region, 2023 & 2033 (%)
4.10 Others
4.10.1 Market Size by Region, 2023-2033 (US$ Mn)
4.10.2 Market Share by Region, 2023 & 2033 (%)

5 Neurostimulation Devices Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Neurostimulation Devices Market Size Estimation and Forecast by Application
5.4 Pain Management
5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Epilepsy
5.5.1 Market Size by Region, 2023-2033 (US$ Mn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Essential Tremor
5.6.1 Market Size by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Urinary and Fecal Incontinence
5.7.1 Market Size by Region, 2023-2033 (US$ Mn)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Depression
5.8.1 Market Size by Region, 2023-2033 (US$ Mn)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Dystonia
5.9.1 Market Size by Region, 2023-2033 (US$ Mn)
5.9.2 Market Share by Region, 2023 & 2033 (%)
5.10 Gastroparesis
5.10.1 Market Size by Region, 2023-2033 (US$ Mn)
5.10.2 Market Share by Region, 2023 & 2033 (%)
5.11 Parkinson’s Disease
5.11.1 Market Size by Region, 2023-2033 (US$ Mn)
5.11.2 Market Share by Region, 2023 & 2033 (%)
5.12 Others
5.12.1 Market Size by Region, 2023-2033 (US$ Mn)
5.12.2 Market Share by Region, 2023 & 2033 (%)

6 Neurostimulation Devices Market Analysis by Region
6.1 Key Findings
6.2 Regional Segment: Market Attractiveness Index
6.3 Neurostimulation Devices Market Size Estimation and Forecast

7 North America Neurostimulation Devices Market Analysis
7.1 Key Findings
7.2 North America Neurostimulation Devices Market Attractiveness Index
7.3 North America Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn)
7.4 North America Neurostimulation Devices Market Size Estimation and Forecast by Country
7.5 North America Neurostimulation Devices Market Size Estimation and Forecast by Product
7.6 North America Neurostimulation Devices Market Size Estimation and Forecast by Application
7.7 U.S. Neurostimulation Devices Market Analysis
7.8 Canada Neurostimulation Devices Market Analysis

8 Europe Neurostimulation Devices Market Analysis
8.1 Key Findings
8.2 Europe Neurostimulation Devices Market Attractiveness Index
8.3 Europe Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn)
8.4 Europe Neurostimulation Devices Market Size Estimation and Forecast by Country
8.5 Europe Neurostimulation Devices Market Size Estimation and Forecast by Product
8.6 Europe Neurostimulation Devices Market Size Estimation and Forecast by Application
8.7 Germany Neurostimulation Devices Market Analysis
8.8 France Neurostimulation Devices Market Analysis
8.9 UK Neurostimulation Devices Market Analysis
8.10 Italy Neurostimulation Devices Market Analysis
8.11 Spain Neurostimulation Devices Market Analysis
8.12 Russia Neurostimulation Devices Market Analysis
8.13 Rest of Europe Neurostimulation Devices Market Analysis

9 Asia Pacific Neurostimulation Devices Market Analysis
9.1 Key Findings
9.2 Asia Pacific Neurostimulation Devices Market Attractiveness Index
9.3 Asia Pacific Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn)
9.4 Asia Pacific Neurostimulation Devices Market Size Estimation and Forecast by Country
9.5 Asia Pacific Neurostimulation Devices Market Size Estimation and Forecast by Product
9.6 Asia Pacific Neurostimulation Devices Market Analysis by Application
9.7 Japan Neurostimulation Devices Market Analysis
9.8 China Neurostimulation Devices Market Analysis
9.9 India Neurostimulation Devices Market Analysis
9.10 Australia Neurostimulation Devices Market Analysis
9.11 South Korea Neurostimulation Devices Market Analysis
9.12 Rest of Asia Pacific Neurostimulation Devices Market Analysis

10 Latin America Neurostimulation Devices Market Analysis
10.1 Key Findings
10.2 Latin America Neurostimulation Devices Market Attractiveness Index
10.3 Latin America Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn)
10.4 Latin America Neurostimulation Devices Market Size Estimation and Forecast by Country
10.5 Latin America Neurostimulation Devices Market Size Estimation and Forecast by Product
10.6 Latin America Neurostimulation Devices Market Size Estimation and Forecast by Application
10.7 Brazil Neurostimulation Devices Market Analysis
10.8 Mexico Neurostimulation Devices Market Analysis
10.9 Rest of Latin America Neurostimulation Devices Market Analysis

11 MEA Neurostimulation Devices Market Analysis
11.1 Key Findings
11.2 MEA Neurostimulation Devices Market Attractiveness Index
11.3 MEA Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn)
11.4 MEA Neurostimulation Devices Market Size Estimation and Forecast by Country
11.5 MEA Neurostimulation Devices Market Size Estimation and Forecast by Product
11.6 MEA Neurostimulation Devices Market Size Estimation and Forecast by Application
11.7 GCC Neurostimulation Devices Market Analysis
11.8 South Africa Neurostimulation Devices Market Analysis
11.9 Rest of MEA Neurostimulation Devices Market Analysis

12 Company Profiles
12.1 Competitive Landscape, 2021
12.1.1 Medtronic
12.1.2 Boston Scientific Corporation
12.1.3 Abbott Laboratories
12.1.4 LivaNova PLC
12.2 Abbott Laboratories
12.2.1 Company Snapshot
12.2.2 Company Overview
12.2.3 Financial Analysis
12.2.3.1 Net Revenue, 2017-2021
12.2.3.2 R&D, 2017-2021
12.2.3.3 Regional Market Shares, 2021
12.2.4 Product Benchmarking
12.2.5 Strategic Outlook
12.3 Advanced Bionics AG (Sonova)
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Product Benchmarking
12.3.4 Strategic Outlook
12.4 Boston Scientific Corporation
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2017-2021
12.4.3.2 R&D, 2017-2021
12.4.3.3 Regional Market Shares, 2021
12.4.4 Product Benchmarking
12.4.5 Strategic Outlook
12.5 BrainCo, Inc
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Product Benchmarking
12.5.4 Strategic Outlook
12.6 Cochlear Limited
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2017-2021
12.6.3.2 R&D, 2017-2021
12.6.3.3 Regional Market Shares, 2021
12.6.4 Product Benchmarking
12.6.5 Strategic Outlook
12.7 ElectroCore Inc
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Financial Analysis
12.7.3.1 Net Revenue, 2017-2021
12.7.3.2 R&D, 2017-2021
12.7.3.3 Regional Market Shares, 2021
12.7.4 Product Benchmarking
12.7.5 Strategic Outlook
12.8 Helbling Holding AG
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2017-2021
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Innovative Health Solutions, Inc
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Product Benchmarking
12.9.4 Strategic Outlook
12.10 LivaNova PLC
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Financial Analysis
12.10.3.1 Net Revenue, 2017-2021
12.10.3.2 R&D, 2017-2021
12.10.3.3 Regional Market Shares, 2021
12.10.4 Product Benchmarking
12.10.5 Strategic Outlook
12.11 Medtronic
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2017-2021
12.11.3.2 R&D, 2017-2021
12.11.3.3 Regional Market Shares, 2021
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 MicroTransponder
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Product Benchmarking
12.12.4 Strategic Outlook
12.13 Neuronetics, Inc
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Financial Analysis
12.13.3.1 Net Revenue, 2017-2021
12.13.3.2 R&D, 2017-2021
12.13.3.3 Regional Market Shares, 2021
12.13.4 Product Benchmarking
12.13.5 Strategic Outlook
12.14 Nihon Kohden Corporation
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Financial Analysis
12.14.3.1 Net Revenue, 2017-2021
12.14.3.2 R&D, 2017-2021
12.14.3.3 Regional Market Shares, 2021
12.14.4 Product Benchmarking
12.14.5 Strategic Outlook
12.15 Natus Medical Incorporated
12.15.1 Company Snapshot
12.15.2 Company Overview
12.15.3 Product Benchmarking
12.15.4 Strategic Outlook
12.16 Parasym Ltd.
12.16.1 Company Snapshot
12.16.2 Company Overview
12.16.3 Product Benchmarking
12.16.4 Strategic Outlook
12.17 Synapse Biomedical Inc
12.17.1 Company Snapshot
12.17.2 Company Overview
12.17.3 Product Benchmarking
12.17.4 Strategic Outlook
12.18 tVNS Technologies GmbH (Cerbomed)
12.18.1 Company Snapshot
12.18.2 Company Overview
12.18.3 Product Benchmarking
12.18.4 Strategic Outlook

13 Conclusion and Recommendations

List of Tables

Table 1 Neurostimulation Devices Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 3 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 4 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 5 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 6 Neurostimulation Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 7 Deep Brain Stimulator Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 8 Gastric Electric Stimulator Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 9 Spinal Cord Stimulator Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 10 Sacral Nerve Stimulator Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 11 Vagus Nerve Stimulator Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 12 Transcutaneous Electrical Nerve Stimulation (TENS)Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 13 Others Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 14 Neurostimulation Devices Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 15 Pain Management Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 16 Epilepsy Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 17 Essential Tremor Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 18 Urinary and Fecal Incontinence Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 19 Depression Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 20 Dystonia Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 21 Gastroparesis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 22 Parkinson’s Disease Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 23 Others Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 24 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 25 North America Neurostimulation Devices Market Forecast by Country
Table 26 North America Neurostimulation Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 27 Neurostimulation Devices Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 28 U.S. Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 29 Canada Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 30 Europe Neurostimulation Devices Market Forecast by Country, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 31 Europe Neurostimulation Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 32 Neurostimulation Devices Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 33 Germany Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 34 France Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 35 UK Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 36 Italy Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 37 Spain Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 38 Russia Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 39 Rest of Europe Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 40 Asia Pacific Neurostimulation Devices Market forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 41 Asia Pacific Neurostimulation Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 42 Neurostimulation Devices Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 43 Japan Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 44 China Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 45 India Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 46 Australia Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 47 South Korea Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 48 Rest of Asia Pacific Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 49 Latin America Neurostimulation Devices Market Forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 50 Latin America Neurostimulation Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 51 Latin America Neurostimulation Devices Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 52 Brazil Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 53 Mexico Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 54 Rest of Latin America Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 55 MEA Neurostimulation Devices forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 56 MEA Neurostimulation Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 57 MEA Neurostimulation Devices Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 58 GCC Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 59 South Africa Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 60 Rest of MEA Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 61 Abbott Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 62 Abbott Laboratories: Product Benchmarking
Table 63 Abbott Laboratories: Strategic Outlook
Table 64 Advanced Bionics AG (Sonova): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 65 Advanced Bionics AG (Sonova).: Product Benchmarking
Table 66 Advanced Bionics AG (Sonova).: Strategic Outlook
Table 67 Boston Scientific Corporation, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 68 Boston Scientific Corporation: Product Benchmarking
Table 69 Boston Scientific Corporation: Strategic Outlook
Table 70 BrainCo, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 BrainCo, Inc.: Product Benchmarking
Table 72 BrainCo, Inc.: Strategic Outlook
Table 73 Cochlear Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Cochlear Limited: Product Benchmarking
Table 75 Cochlear Limited: Strategic Outlook
Table 76 ElectroCore Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 ElectroCore Inc.: Product Benchmarking
Table 78 ElectroCore Inc.: Strategic Outlook
Table 79 Helbling Holding AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Helbling Holding AG: Product Benchmarking
Table 81 Helbling Holding AG: Strategic Outlook
Table 82 Innovative Health Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Innovative Health Solutions: Product Benchmarking
Table 84 Innovative Health Solutions: Strategic Outlook
Table 85 LivaNova PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 LivaNova PLC: Product Benchmarking
Table 87 LivaNova PLC: Strategic Outlook
Table 88 Medtronic: (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Medtronic: Product Benchmarking
Table 90 Medtronic: Strategic Outlook
Table 91 MicroTransponder: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 MicroTransponder: Product Benchmarking
Table 93 MicroTransponder: Strategic Outlook
Table 94 Neuronetics, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Neuronetics, Inc.: Product Benchmarking
Table 96 Neuronetics, Inc.: Strategic Outlook
Table 97 Nihon Kohden Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Nihon Kohden Corporation: Product Benchmarking
Table 99 Nihon Kohden Corporation: Strategic Outlook
Table 100 Natus Medical Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Natus Medical Incorporated: Product Benchmarking
Table 102 Natus Medical Incorporated: Strategic Outlook
Table 103 Parasym Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Parasym Ltd.: Product Benchmarking
Table 105 Parasym Ltd.: Strategic Outlook
Table 106 Synapse Biomedical Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Synapse Biomedical Inc.: Product Benchmarking
Table 108 Synapse Biomedical Inc.: Strategic Outlook
Table 109 tVNS Technologies GmbH (Cerbomed): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 tVNS Technologies GmbH (Cerbomed).: Product Benchmarking
Table 111 tVNS Technologies GmbH (Cerbomed).: Strategic Outlook

List of Figures


Figure 1 Neurostimulation Devices Market Segmentation
Figure 2 Neurostimulation Devices Market by Product: Market Attractiveness Index
Figure 3 Neurostimulation Devices Market by Application: Market Attractiveness Index
Figure 4 Neurostimulation Devices Market Attractiveness Index by Region
Figure 5 Neurostimulation Devices Market: Market Dynamics
Figure 6 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 7 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 8 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 9 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 10 Neurostimulation Devices Market: Porter’s Five Forces Analysis
Figure 11 Neurostimulation Devices Market: PEST Analysis
Figure 12 Neurostimulation Devices Market by Product: Market Attractiveness Index
Figure 13 Neurostimulation Devices Market Forecast by Product, 2023-2033 (US$ million)
Figure 14 Neurostimulation Devices Market Share Forecast by Product, 2023, 2033 (%)
Figure 15 Deep Brain Stimulator Market Forecast by Region, 2023-2033 (US$ million)
Figure 16 Deep Brain Stimulator Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 Gastric Electric Stimulator Market Forecast by Region, 2023-2033 (US$ million)
Figure 18 Gastric Electric Stimulator Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Spinal Cord Stimulator Market Forecast by Region, 2023-2033 (US$ million)
Figure 20 Spinal Cord Stimulator Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Sacral Nerve Stimulator Market Forecast by Region, 2023-2033 (US$ million)
Figure 22 Sacral Nerve Stimulator Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Vagus Nerve Stimulator Market Forecast by Region, 2023-2033 (US$ million)
Figure 24 Vagus Nerve Stimulator Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Transcutaneous Electrical Nerve Stimulation (TENS) Market Forecast by Region, 2023-2033 (US$ million)
Figure 26 Transcutaneous Electrical Nerve Stimulation (TENS) Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 28 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Neurostimulation Devices Market by Application: Market Attractiveness Index
Figure 30 Neurostimulation Devices Market Forecast by Application, 2023-2033 (US$ million)
Figure 31 Neurostimulation Devices Market Share Forecast by Application, 2023 & 2033 (%)
Figure 32 Pain Management Market Forecast by Region, 2023-2033 (US$ million)
Figure 33 Pain Management Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Epilepsy Market Forecast by Region, 2023-2033 (US$ million)
Figure 35 Epilepsy Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Essential Tremor Market Forecast by Region, 2023-2033 (US$ million)
Figure 37 Essential Tremor Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Urinary and Fecal Incontinence Market Forecast by Region, 2023-2033 (US$ million)
Figure 39 Urinary and Fecal Incontinence Market Share Forecast by Region, 2023 & 2033 (%)
Figure 40 Depression Market Forecast by Region, 2023-2033 (US$ million)
Figure 41 Depression Market Share Forecast by Region, 2023 & 2033 (%)
Figure 42 Dystonia Market Forecast by Region, 2023-2033 (US$ million)
Figure 43 Dystonia Market Share Forecast by Region, 2023 & 2033 (%)
Figure 44 Gastroparesis Market Forecast by Region, 2023-2033 (US$ million)
Figure 45 Gastroparesis Market Share Forecast by Region, 2023 & 2033 (%)
Figure 46 Parkinson’s Disease Market Forecast by Region, 2023-2033 (US$ million)
Figure 47 Parkinson’s Disease Market Share Forecast by Region, 2023 & 2033 (%)
Figure 48 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 49 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 50 Neurostimulation Devices Market by Region: Market Attractiveness Index
Figure 51 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn)
Figure 52 Neurostimulation Devices Market Share Forecast by Region 2023, 2033(%)
Figure 53 North America Neurostimulation Devices Market Attractiveness Index
Figure 54 North America Neurostimulation Devices Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 55 North America Neurostimulation Devices Market Forecast by Country, 2023-2033 (US$ million)
Figure 56 North America Neurostimulation Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 57 North America Neurostimulation Devices Market Forecast by Product, 2023-2033 (US$ million)
Figure 58 North America Neurostimulation Devices Market Share Forecast by Product, 2023 & 2033 (%)
Figure 59 North America Neurostimulation Devices Market Forecast by Application, 2023-2033 (US$ million)
Figure 60 North America Neurostimulation Devices Market Share Forecast by Application, 2023 & 2033 (%)
Figure 61 U.S. Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 62 Canada Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 63 Europe Neurostimulation Devices Market Attractiveness Index
Figure 64 Europe Neurostimulation Devices Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 65 Europe Neurostimulation Devices Market Forecast by Country, 2023-2033 (US$ million)
Figure 66 Europe Neurostimulation Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 67 Europe Neurostimulation Devices Market Forecast by Product, 2023-2033 (US$ million)
Figure 68 Europe Neurostimulation Devices Market Share Forecast by Product, 2023 & 2033 (%)
Figure 69 Europe Neurostimulation Devices Market Forecast by Application, 2023-2033 (US$ million)
Figure 70 Europe Neurostimulation Devices Market Share Forecast by Application, 2023 & 2033 (%)
Figure 71 Germany Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 72 France Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 73 UK Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 74 Italy Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 75 Spain Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 76 Russia Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 77 Rest of Europe Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 78 Asia Pacific Neurostimulation Devices Market Attractiveness Index
Figure 79 Asia Pacific Neurostimulation Devices Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 80 Asia Pacific Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 81 Asia Pacific Neurostimulation Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 82 Asia Pacific Neurostimulation Devices Market Forecast by Product, 2023-2033 (US$ million, AGR %)
Figure 83 Asia Pacific Neurostimulation Devices Market Share Forecast by Product, 2023 & 2033 (%)
Figure 84 Asia Pacific Neurostimulation Devices Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 85 Asia Pacific Neurostimulation Devices Market Share Forecast by Application, 2023 & 2033 (%)
Figure 86 Japan Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 87 China Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 88 India Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 89 Australia Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 90 South Korea Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 91 Rest of Asia Pacific Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 92 Latin America Neurostimulation Devices Market Attractiveness Index
Figure 93 Latin America Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ million)
Figure 94 Latin America Neurostimulation Devices Market Forecast by Country, 2023-2033 (US$ million)
Figure 95 Latin America Neurostimulation Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 96 Latin America Neurostimulation Devices Market Forecast by Product, 2023-2033 (US$ million)
Figure 97 Latin America Neurostimulation Devices Market Share Forecast by Product, 2023 & 2033 (%)
Figure 98 Latin America Neurostimulation Devices Market Forecast by Application, 2023-2033 (US$ million)
Figure 99 Latin America Neurostimulation Devices Market Share Forecast by Application, 2023 & 2033 (%)
Figure 100 Brazil Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 101 Mexico Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 102 Rest of Latin America Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 103 MEA Neurostimulation Devices Market Attractiveness Index
Figure 104 MEA Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ million)
Figure 105 MEA Neurostimulation Devices Market Forecast by Country, 2023-2033 (US$ million)
Figure 106 MEA Neurostimulation Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 107 MEA Neurostimulation Devices Market Forecast by Product, 2023-2033 (US$ million)
Figure 108 MEA Neurostimulation Devices Market Share Forecast by Product, 2023 & 2033 (%)
Figure 109 MEA Neurostimulation Devices Market Forecast by Application, 2023-2033 (US$ million)
Figure 110 MEA Neurostimulation Devices Market Share Forecast by Application, 2023 & 2033 (%)
Figure 111 GCC Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 112 South Africa Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 113 Rest of MEA Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 114 Company Share Analysis, 2021
Figure 115 Abbott Laboratories: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 116 Abbott Laboratories: R&D, 2017-2021 (US$ million, AGR%)
Figure 117 Abbott Laboratories: Regional Market Shares, 2021
Figure 118 Boston Scientific Corporation.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 119 Boston Scientific Corporation.: R&D, 2017-2021 (US$ million, AGR%)
Figure 120 Boston Scientific Corporation: Regional Market Shares, 2021
Figure 121 Cochlear Limited: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 122 Cochlear Limited.: R&D, 2017-2021 (US$ million, AGR%)
Figure 123 Cochlear Limited.: Regional Market Shares, 2021
Figure 124 ElectroCore Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 125 ElectroCore Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 126 ElectroCore Inc.: Regional Market Shares, 2021
Figure 127 Helbling Holding AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 128 LivaNova PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 129 LivaNova PLC.: R&D, 2017-2021 (US$ million, AGR%)
Figure 130 LivaNova PLC.: Regional Market Shares, 2021
Figure 131 Medtronic: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 132 Medtronic.: R&D, 2017-2021 (US$ million, AGR%)
Figure 133 Medtronic.: Regional Market Shares, 2021
Figure 134 Neuronetics, Inc: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 135 Neuronetics, Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 136 Neuronetics, Inc.: Regional Market Shares, 2021
Figure 137 Nihon Kohden Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 138 Nihon Kohden Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 139 Nihon Kohden Corporation: Regional Market Shares, 2021